Cervical cancer
Journal article
Reasons that clinicians in Australia offer cervical screening outside guidelines for frequency, age and co-testing
This study investigates clinicians’ adherence to revised cervical screening guidelines and aims to identify any reasons for them screening women outside the revised guidelines.
Journal article
Renewal of the National Cervical Screening Program: health professionals’ knowledge about screening of specific populations in NSW, Australia
The National Cervical Screening Program was renewed in Australia from 1 December 2017, with the introduction of 5-yearly human papilloma virus (HPV) screening from age 25, and the release of updated national screening guidelines. This study aimed to determine health professional knowledge of the renewed screening program following implementation.
Journal article
Why would a woman screen? Facilitators and barriers for women least likely to participate in cervical screening in Australia
This study aimed to gain insight into factors influencing cervical screening among women from a area in Western Sydney characterised by disadvantage and ethnic diversity, and which has one of the lowest participation rates in the National Cervical Screening Program.
Journal article
Barriers and facilitators to participation in breast, bowel and cervical cancer screening in rural Victoria: a qualitative study
Population cancer screening rates are around 50% for the general population and even lower in rural areas. This study aimed to explore knowledge, attitudes, behaviours, motivators and barriers to breast, bowel and cervical screening participation in under-screened men and women with the aim of increasing cancer screening participation in under-screened rural populations.
Report
National Cervical Screening Program monitoring report 2020
The National Cervical Screening Program (NCSP) is one of Australia’s three population-based cancer screening programs. This is the second report to monitor the National Cervical Screening Program since it introduced 5-yearly HPV tests in 2017.